Featured resources
CRO Selection Checklist: 38 Things to Know
Selecting a CRO is a complicated process. Start your search with our free CRO Selection Checklist, detailing 38 things to look out for ...
Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs
This brief guide provides timeline benchmarks for Sponsors evaluating biometrics contract research organizations (CROs) ...
Browse all resources
75+ free resources from PharPoint | Insight, checklists, & more
Achieving Expedited Database Lock with Director of DM, Wendy Moffett
Director of Data Management Wendy Moffett discusses how PharPoint achieves rapid database lock in this short video ...
Contract Research Organizations 101: What is a CRO?
What does a CRO do? Go back to basics with us ...
Effective Site Feasibility: It all Starts with a Protocol and a Question(naire)
Learn what goes into an effective site feasibility questionnaire and how an experienced consultant can help inform your strategy ...
No Surprises: PharPoint’s Transparent Approach to Changes in Scope
How does your CRO handle changes in scope (CIS)? Learn more about PharPoint's transparent process ...
Phase 1 CRO Project Management: Avoiding Delays
Thorough planning is especially critical for Phase 1 trials, as even minor delays can cause major downstream effects ...
A Guide to Reviewing Regulatory Documents as a Subject Matter Expert (SME)
We discuss best practices to allow a reviewer to effectively and efficiently provide critical input to regulatory documents ...
Four Signs It is Time to Break Up with Your Regulatory Medical Writing Vendor
Explore some of the standards should you expect from your regulatory medical writing partner ...
Building Stronger Relationships between CROs and Small Biopharma: Ensuring Your Voice is Heard
Explore how effective communication and collaboration builds successful partnerships ...
Early Study Actions to Help Set a Rare Disease Clinical Trial Up for Success
What early tactics should you consider to improve your chances of a successful rare disease trial? ...
